AKT1 and hepatocellular carcinoma: Studies on in vitro models of hepatoma cells have revealed that L-theanine can significantly suppress the Met/EGFR/VEGFR-Akt/NF-κB pathway, thereby inhibiting the growth of hepatoma cells [133].